These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 3643740)

  • 21. Chromogenic peptide substrate assays for determining components of the plasma kallikrein system.
    Gallimore MJ
    Scand J Clin Lab Invest Suppl; 1985; 178():127-32. PubMed ID: 3867113
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Functional characterization of a variant factor XII (F XII Locarno) in a cross reacting material positive F XII deficient plasma.
    Wuillemin WA; Furlan M; Stricker H; Lämmle B
    Thromb Haemost; 1992 Feb; 67(2):219-25. PubMed ID: 1621242
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacological regulation of factor XII activation may be a new target to control pathological coagulation.
    Schousboe I
    Biochem Pharmacol; 2008 Mar; 75(5):1007-13. PubMed ID: 17996217
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A nanobody-based method for tracking factor XII activation in plasma.
    de Maat S; van Dooremalen S; de Groot PG; Maas C
    Thromb Haemost; 2013 Sep; 110(3):458-68. PubMed ID: 23349032
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A comparison of the effects of factor XII deficiency and prekallikrein deficiency on thrombus formation.
    Kokoye Y; Ivanov I; Cheng Q; Matafonov A; Dickeson SK; Mason S; Sexton DJ; Renné T; McCrae K; Feener EP; Gailani D
    Thromb Res; 2016 Apr; 140():118-124. PubMed ID: 26950760
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [New dipeptide fluorogenic substrates of human tissue kallikrein].
    Pozdnev VF; Rabinovich SE; Paskhina TS
    Bioorg Khim; 1991 Oct; 17(10):1352-6. PubMed ID: 1804119
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ELISA for determination of total coagulation factor XII concentration in human plasma.
    Madsen DE; Sidelmann JJ; Overgaard K; Koch C; Gram JB
    J Immunol Methods; 2013 Aug; 394(1-2):32-9. PubMed ID: 23639297
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Centrifugal analysis for plasma kallikrein activity, with use of the chromogenic substrate S-2302.
    Ito R; Statland BE
    Clin Chem; 1981 Apr; 27(4):586-93. PubMed ID: 6907061
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Coagulation factor XII Locarno: the functional defect is caused by the amino acid substitution Arg 353-->Pro leading to loss of a kallikrein cleavage site.
    Hovinga JK; Schaller J; Stricker H; Wuillemin WA; Furlan M; Lämmle B
    Blood; 1994 Aug; 84(4):1173-81. PubMed ID: 8049433
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fibrinolytic properties of activated FXII.
    Braat EA; Dooijewaard G; Rijken DC
    Eur J Biochem; 1999 Aug; 263(3):904-11. PubMed ID: 10469157
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A common neoepitope is created when the reactive center of C1-inhibitor is cleaved by plasma kallikrein, activated factor XII fragment, C1 esterase, or neutrophil elastase.
    de Agostini A; Patston PA; Marottoli V; Carrel S; Harpel PC; Schapira M
    J Clin Invest; 1988 Aug; 82(2):700-5. PubMed ID: 2457036
    [TBL] [Abstract][Full Text] [Related]  

  • 32. C1-inhibitor polymers activate the FXII-dependent kallikrein-kinin system: Implication for a role in hereditary angioedema.
    Madsen DE; Sidelmann JJ; Biltoft D; Gram J; Hansen S
    Biochim Biophys Acta; 2015 Jun; 1850(6):1336-42. PubMed ID: 25800206
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The use of a tripeptide chromogenic substrate for simultaneous determination of 4 indices of kallikrein-kinin system].
    Dotsenko VL; Iarovaia GA; Neshkova EA
    Vopr Med Khim; 1989; 35(2):128-33. PubMed ID: 2741408
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Heparin modulation of human plasma kallikrein on different substrates and inhibitors.
    Gozzo AJ; Nunes VA; Cruz-Silva I; Carmona AK; Nader HB; Faljoni-Alario A; Sampaio MU; Araújo MS
    Biol Chem; 2006 Aug; 387(8):1129-38. PubMed ID: 16895484
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A monoclonal antibody raised against human beta-factor XIIa which also recognizes alpha-factor XIIa but not factor XII or complexes of factor XIIa with C1 esterase inhibitor.
    Esnouf MP; Burgess AI; Dodds AW; Sarphie AF; Miller GJ
    Thromb Haemost; 2000 Jun; 83(6):874-81. PubMed ID: 10896241
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cold promoted activation and factor XII, prekallikrein and C1-inhibitor.
    Czendlik C; Lämmle B; Duckert F
    Thromb Haemost; 1985 Apr; 53(2):242-4. PubMed ID: 2410997
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Purification of guinea-pig plasma prekallikrein. Activation by prekallikrein activator derived from guinea-pig skin.
    Yamamoto T; Kozono K; Okamoto T; Kato H; Kambara T
    Biochim Biophys Acta; 1980 Aug; 614(2):511-25. PubMed ID: 6967737
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Contact factor proteases and the complexes formed with alpha 2-macroglobulin can interfere in protein C assays by cleaving amidolytic substrates.
    Mackie IJ; Gallimore M; Machin SJ
    Blood Coagul Fibrinolysis; 1992 Oct; 3(5):589-95. PubMed ID: 1280470
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis and hydrolysis by arginyl-hydrolases of p-nitroanilide chromogenic substrates containing polyethylene glycol and D-gluconyl moieties.
    Juliano MA; Juliano L; Biondi L; Rocchi R
    Pept Res; 1991; 4(6):334-9. PubMed ID: 1821168
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Part of purified human plasma kallikrein removed together with a remaining IgG fraction--immunoblot experiments and functional tests.
    Briseid K; Johannesen S
    Scand J Clin Lab Invest; 2002; 62(1):21-4. PubMed ID: 12002409
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.